{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:30:07Z","timestamp":1787841007241,"version":"build-2784847793"},"reference-count":40,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2026,7,24]]},"DOI":"10.1080\/17576180.2026.2715920","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:10:55Z","timestamp":1786947055000},"page":"1015-1029","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["A validated bioanalytical LC-MS\/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasma"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2521-4358","authenticated-orcid":false,"given":"Fatma H.","family":"Ghazy","sequence":"first","affiliation":[{"name":"Cairo University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzia I.","family":"El-Bagary","sequence":"additional","affiliation":[{"name":"Cairo University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar H.","family":"Fahim","sequence":"additional","affiliation":[{"name":"Cairo University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally T.","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Cairo University","place":["Cairo, Egypt"]},{"name":"School of Pharmacy, New Giza","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-021-04325-9"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01367-z"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105871"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2422"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-074572"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac180"},{"key":"e_1_3_7_9_1","unstructured":"Fischer W Eron JJ Holman W et al. Molnupiravir an oral antiviral treatment for COVID-19. medRxiv Prepr Serv Heal Sci [Internet]. 2021; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34159342%0Ahttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC8219109"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102329"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.909"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00288-20"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2438"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141772"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00331-3"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.02.023"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031994"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27482"},{"key":"e_1_3_7_19_1","volume-title":"Frequently asked questions on olumiant (baricitinib) for the treatment of COVID-19","author":"Food and Drug Adminstration","year":"2022","unstructured":"Food and Drug Adminstration. Frequently asked questions on olumiant (baricitinib) for the treatment of COVID-19. 2022."},{"key":"e_1_3_7_20_1","unstructured":"Coronavirus (COVID-19) update: FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults | FDA [Internet]. [cited 2025 Jul 8]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44756-6"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123363"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.122921"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114356"},{"issue":"2","key":"e_1_3_7_25_1","first-page":"233","article-title":"Development and validation of a high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS\/MS) method for quantification of Major Molnupiravir metabolite (\u03b2-D-N4-hydroxycytidine) in human plasma","volume":"13","author":"Vetrova ES","year":"2024","unstructured":"Vetrova ES, Karnakova PK, Bagaeva NS, et al. Development and validation of a high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS\/MS) method for quantification of Major Molnupiravir metabolite (\u03b2-D-N4-hydroxycytidine) in human plasma. Drug Dev Regist. 2024;13(2):233\u2013244.","journal-title":"Drug Dev Regist"},{"issue":"258","key":"e_1_3_7_26_1","first-page":"1","article-title":"A comprehensive review on analytical and bioanalytical methods of molnupiravir","volume":"2","author":"Gandi A","year":"2025","unstructured":"Gandi A, Shaik S, Rongali C, et al. A comprehensive review on analytical and bioanalytical methods of molnupiravir. Discov Chem. 2025;2(258):1\u201321.","journal-title":"Discov Chem"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001128"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S509176"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071600"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2026.124927"},{"key":"e_1_3_7_31_1","unstructured":"U.S. Department of Health and Human Services. Food and drug administration. Guidance for industry: bioanalytical method validation. Fda [Internet]. 2001. p. 4\u201310. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02428-20"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac199"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.354"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12486"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.868"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.6c00002"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0AY02169E"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-026-06677-x"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2012.03.013"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2026.118329"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2715920","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17576180.2026.2715920","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2715920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:37:19Z","timestamp":1787837839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2026.2715920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,7,24]]}},"alternative-id":["10.1080\/17576180.2026.2715920"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2026.2715920","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}